SELLAS Life Sciences Group, Inc. — Director's Dealing 2013

Nov 28, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Galena Biopharma, Inc. (GALE)
CIK: 0001390478
Period of Report: 2013-11-26

Reporting Person: Nisi Rudolph (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-11-26	Stock Option (right to buy)	$3.88	A	200000	Acquired	2023-11-26	Common Stock (200000)	Direct

Footnotes

F1: Granted pursuant to the Issuer's Amended and Restated 2007 Incentive Plan.

F2: The options will vest in equal quarterly installments of 50,000 shares on each of February 26, 2014, May 26, 2014, August 26, 2014 and November 26, 2014.